IRIS
SPAGNOLO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.458
Totale 1.458
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.458
Totale 1.458
Salva come PNG Salva come JPEG
Città #
Genova 638
Rapallo 427
Genoa 378
Bordighera 15
Totale 1.458
Salva come PNG Salva come JPEG
Nome #
Analisi fenotipica e funzionale dell’infiltrato linfocitario in biopsie di metastasi di melanoma, in pazienti in terapia con farmaci a bersaglio molecolare e/o inibitori dei checkpoint immunologici, file e268c4cc-5b4e-a6b7-e053-3a05fe0adea1 795
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry, file e268c4c7-850d-a6b7-e053-3a05fe0adea1 110
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies., file e268c4ca-a329-a6b7-e053-3a05fe0adea1 102
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148, file e268c4ca-c82b-a6b7-e053-3a05fe0adea1 100
Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function, file e268c4ca-638a-a6b7-e053-3a05fe0adea1 91
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204, file e268c4ca-e751-a6b7-e053-3a05fe0adea1 70
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations, file e268c4c9-cdb3-a6b7-e053-3a05fe0adea1 64
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization, file e268c4cc-4ff2-a6b7-e053-3a05fe0adea1 41
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis, file e268c4ce-ae35-a6b7-e053-3a05fe0adea1 25
How I perform fertility preservation in breast cancer patients, file e268c4cd-a9cb-a6b7-e053-3a05fe0adea1 23
Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient, file e268c4cd-64ab-a6b7-e053-3a05fe0adea1 4
How to make immunotherapy an effective therapeutic choice for uveal melanoma, file e268c4ce-6706-a6b7-e053-3a05fe0adea1 4
Molecular Assessment in Patients with Melanoma: When and Why?, file 0cac9e34-ffdc-42c4-b747-3f7c10db946e 3
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1, file e268c4cc-9aa1-a6b7-e053-3a05fe0adea1 3
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients, file e268c4cc-c04a-a6b7-e053-3a05fe0adea1 3
Current State of Target Treatment in BRAF Mutated Melanoma, file e268c4cc-fd6b-a6b7-e053-3a05fe0adea1 3
Regenerative surgery for the definitive repair of a vasculitic nonhealing ulcer using platelet-derived growth factors and noncultured autologous cell suspension, file e268c4c6-af44-a6b7-e053-3a05fe0adea1 2
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients, file e268c4c9-cdb7-a6b7-e053-3a05fe0adea1 2
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup, file e268c4ca-aee7-a6b7-e053-3a05fe0adea1 2
HO-1 downregulation favors BRAFV600 melanoma cell death induced by Vemurafenib/PLX4032 and increases NK recognition, file e268c4cb-4040-a6b7-e053-3a05fe0adea1 2
Efficacy of braf and mek inhibition in patients with braf‐mutant advanced melanoma and germline cdkn2a pathogenic variants, file e268c4cd-d574-a6b7-e053-3a05fe0adea1 2
Immunotherapy in Adolescents and Young Adults: What Remains in Cancer Survivors?, file e268c4ce-ae2c-a6b7-e053-3a05fe0adea1 2
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature, file 8df1586a-a3d6-4a40-acaf-d13c82f7bc9a 1
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review, file e268c4c9-f2d3-a6b7-e053-3a05fe0adea1 1
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab, file e268c4ca-15ec-a6b7-e053-3a05fe0adea1 1
The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival, file e268c4ca-38e7-a6b7-e053-3a05fe0adea1 1
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab, file e268c4cd-3eb9-a6b7-e053-3a05fe0adea1 1
Totale 1.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.705
article - articoli 1.634
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3
Totale 4.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020108 1 0 0 0 1 1 19 16 25 15 19 11
2020/2021168 9 12 16 7 16 8 16 10 13 16 22 23
2021/2022374 24 22 15 22 26 28 30 29 24 32 80 42
2022/2023497 21 18 54 58 39 74 45 47 37 51 38 15
2023/2024309 12 20 31 32 54 21 44 42 18 27 8 0
Totale 1.458